journal club : benefits and risks of tight glucose control in critically ill adults: a meta-analysis

Upload: tomoe-hotaru

Post on 30-May-2018

219 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/14/2019 Journal Club : Benefits and risks of tight glucose control in critically ill adults: a meta-analysis

    1/3

    Benefits and risks of tight glucose control in critically ill adults: a meta-analysis1

    Wiener RS, Wiener DC, Larson RJ.JAMA. August 27, 2008; 300 (8): 933-944

    Journal Club Presentation by Quang Bui, Pharm D. candidate 2010. Touro University. 9/22/08

    Background

    - An RCT by Van den Berghe et al shows that tight glucose control may reduce hospital mortality

    by one third.2

    - Recommendations were incorporated into the Surviving Sepsis Campaign and many other

    guidelines worldwide.3

    - Later RCT studies have not shown the same benefits. Eg. the same investigator find no benefits

    for critically ill patients in ICU.4

    Methods

    - Search strategy : MEDLINE (1950-June 6, 2008) with MeSH, Cochrane Library (issue 1, 2008)

    and multiple trial registries such as clinicaltrials.gov (August 2007).

    - Study selection contact investigators of unpublished data to confirm eligibility.

    Inclusion criteria of RCTs Exclusion criteria of RCTs- adult ICU setting

    - intervention grp received tight Glc control (Glc goal

    500 patients (21 with 100 patients, 7 with >500

  • 8/14/2019 Journal Club : Benefits and risks of tight glucose control in critically ill adults: a meta-analysis

    2/3

    patients), ages 46-75, 31-95% males, 0-100% diabetics, and APACHE II scores 9-32; 2 studies

    have discrepant baseline between intervention vs control; all have follow-up rate 80% or higher

    & no double-blind, none has Jadad quality score higher than 3 of 5; target vs achieved Glc levels

    varied.

    Primary outcome Hospital mortality 27/29 trials show no differences.

    No differences in both stratifications.Funnel plot shows no publication bias.

    Secondary outcome Septicemia

    (9 trials)

    Tight Glc control assoc with significant reduced

    risk of septicemia; stratified favor ICU patients &

    moderately tight Glc control.

    Van den Berghe et al study as outlier.

    New dialysis need

    (9 trials)

    No significant association; no in stratification.

    Van den Berghe et al study as outlier.

    Hypoglycemia(15 trials)

    Tight Glc control assoc with increased risk ofhypoglycemia by 5 fold; fairly consistent across

    ICU settings & 2 outliers in medical ICU.

    Conclusion- Tight Glc control was not associated with significant reduction in hospital mortality or new

    dialysis need, but had increased hypoglycemia risk.

    - In stratified group: reduced septicemia in surgical ICU.

    - Therefore, recommend re-evaluation of guidelines.

    - 3 reasons why the van der Berghe et al study is an outlier: bias, chance, and atypical clinical

    practices.

    Discussion

    - Weaknesses

    o Meta-analysis: are all the studies comparable? Jadad quality scores of 3 or less.

    o Only 2 un-blinded reviewers (RSW & DCW) with disputes resolved via discussions.

    o Most studies in the study were low powered and single-centered. Cant get anything that

    the studies dont report.

    o External validity: can not apply this findings to larger population

    - Strengths

    o 1358 relevant studies from MEDLINE, Cochrane, clinical trial registries, and conferences

    from different countries.

    o High internal validity: meta-analysis is easier to replicate than the van der Berghe et al

    study with selective criteria.

    o Articles gathered are mostly from 2006. The oldest from 1991.

    - Recommendations

    o This analysis is a fine example of why guidelines are changing constantly.

    o Tight glucose control may be too critical in severely ill patients who are at high risks ofhypoglycemia. A high powered RCT is needed to solidify these results.

    Resources1. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis.

    JAMA. 2008; 300 (8): 933-944.

    2. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients.NEJM. 2001;345 (19): 1359-1367.

    3. Dellinger RP, Levy M, Carlet J, et al. Surviving sepsis campaign: international guidelines for management of severesepsis and septic shock: 2008.Intensive Care Med. 2008; 34 (1): 17-60.

  • 8/14/2019 Journal Club : Benefits and risks of tight glucose control in critically ill adults: a meta-analysis

    3/3

    4. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU.NEJM. 2006; 354

    (5):449-461.